Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Capranico

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Cancer|May 3, 1996
Interaction of ionizing radiation with topotecan in two human tumor cell linesR Marchesini, A Colombo, C Caserini, et al.
Journal of Medicinal Chemistry|August 2, 1996
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activityB Gatto, G Zagotto, C Sissi, et al.
Pharmacology & Therapeutics|April 16, 1998
New developments in antitumor anthracyclinesF Arcamone, F Animati, G Capranico, et al.
Molecular Pharmacology|December 1, 1996
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180)M Cornarotti, S Tinelli, E Willmore, et al.
International Journal of Cancer|July 4, 1995
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistanceM Binaschi, R Supino, R A Gambetta, et al.
International Journal of Cancer|August 7, 1996
Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinomaM Cornarotti, G Capranico, S Bohm, et al.
Journal of the National Cancer Institute|November 18, 1992
Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell lineM Binaschi, G Giaccone, A F Gazdar, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Anthracyclines: selected new developmentsM Binaschi, M Bigioni, A Cipollone, et al.
The Journal of Biological Chemistry|May 28, 1998
Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congenersG Capranico, F Guano, S Moro, et al.
Chemico-Biological Interactions|February 1, 1986
Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cellsG Capranico, N Babudri, G Casciarri, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|May 3, 1996
Interaction of ionizing radiation with topotecan in two human tumor cell linesR Marchesini, A Colombo, C Caserini, et al.
Journal of Medicinal Chemistry|August 2, 1996
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activityB Gatto, G Zagotto, C Sissi, et al.
Pharmacology & Therapeutics|April 16, 1998
New developments in antitumor anthracyclinesF Arcamone, F Animati, G Capranico, et al.
Molecular Pharmacology|December 1, 1996
Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180)M Cornarotti, S Tinelli, E Willmore, et al.
International Journal of Cancer|July 4, 1995
MRP gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistanceM Binaschi, R Supino, R A Gambetta, et al.
International Journal of Cancer|August 7, 1996
Gene expression of DNA topoisomerases I, II alpha and II beta and response to cisplatin-based chemotherapy in advanced ovarian carcinomaM Cornarotti, G Capranico, S Bohm, et al.
Journal of the National Cancer Institute|November 18, 1992
Characterization of a topoisomerase II gene rearrangement in a human small-cell lung cancer cell lineM Binaschi, G Giaccone, A F Gazdar, et al.
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Anthracyclines: selected new developmentsM Binaschi, M Bigioni, A Cipollone, et al.
The Journal of Biological Chemistry|May 28, 1998
Mapping drug interactions at the covalent topoisomerase II-DNA complex by bisantrene/amsacrine congenersG Capranico, F Guano, S Moro, et al.
Chemico-Biological Interactions|February 1, 1986
Lack of effect of glutathione depletion on cytotoxicity, mutagenicity and DNA damage produced by doxorubicin in cultured cellsG Capranico, N Babudri, G Casciarri, et al.
Pageof 9